Clinical Trials

Search Available Compounds by Structure

List Your Company
Advertise Here
Submit Press Release

SEARCH Bio Expo Online

Home News Search Register Login

Bio Expo Online

Clinical Trials News

3rd annual Allergies conference on July 6-7, 2016 in Central London, UK - SMi Group is thrilled to present the 3rd annual Allergies conference, taking place on 6th & 7th July 2016 in Central London, UK. Aimed at an audience of senior scientists and allergy specialists involved in immunology and drug research, Allergies 2016 will provide the perfect platform to discuss pioneering clinical developments and the next generation […]
5th annual ADC Summit London on May 23-24, 2016 - SMi’s 5th annual ADC Summit provides a comprehensive analysis of the various approaches with the next generation ADCs. Hear the latest insights from Takeda on Adcetris; discuss the latest advancements in research and development from Medimmune; and analyse case studies from big pharma companies such as Roche, Bayer, Pfizer, AstraZeneca, Novartis and many more. Join […]
10th Annual Clinical Trial Logistics 2016 London on 18th & 19th May 2016 - Registration is now live to attend the 10th annual Clinical Trial Logistics conference taking place in London on 18th & 19th May 2016. The implementation of Annex 15 of the Good Manufacturing Practice in Autumn 2015 provided a huge change in the regulatory landscape of the rapidly growing clinical trial supplies industry, with logistics and […]
3rd Allergy, Asthma, & COPD Conference January 25-26, 2016, San Diego, CA - GTCbio is delighted to present the 3rd Allergy, Asthma, & COPD Conference, to be held on January 25-26, 2016 in San Diego, CA. The conference will bring together industry, academia and government experts in the field of allergy, asthma and COPD. Experts will facilitate discourse on the challenges and opportunities for therapeutic and drug development […]
Enzymes in Drug Discovery Summit February 29 – March 2, 2016, San Diego, CA - We are excited to announce the Enzymes in Drug Discovery Summit, which will take place February 29 – March 2, 2016 in San Diego, CA. Enzymes have proven to be an important group of drug targets in diseases, and enzyme inhibitors have been among the most successful of drugs. Join us as we discuss ways […]
Antibody Drug Conjugates Conference October 22-23, 2015, Boston, MA - We invite you to attend the Antibody Drug Conjugates Conference, which will take place October 22-23, 2015 in Boston, MA. This event will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain a fresh perspective on the emergence of […]
Biomarker Summit Europe 2015 on October 5-8, 2015 in Berlin, Germany - The summit will address the latest developments in the biomarker arena from discovery to translation to commercialization. Presentations span across multiple disciplines and cover topics such as discovery and validation strategies, the challenges of clinical translation, novel technologies including next-generation sequencing, regulatory and reimbursement issues and companion diagnostics. Scientific data, case studies and discussions will […]
2nd Bioanalytic Sensors Conference May 5 – 6, 2015, Berlin, Germany - The 2nd Bioanalytic Sensors Conference will take place on May 5 – 6, 2015 in Berlin, Germany. This premier conference will host an exciting group of professionals from the academic, biotech, pharmaceutical, and business communities, and will focus on the latest discoveries in the Bioanlytical Sensors field. A balance of both academic and industry experts […]
Therapeutic Antibody Drugs Being Designed for Self-Administration as Developers Seek Competitive Advantage - Pipeline Candidates Being Formulated for Subcutaneous Delivery Proliferating according to Greystone Research Associates (Amherst, NH) – The administration of therapeutic antibodies is becoming an increasingly important healthcare treatment option for a growing number diseases and indications having broad implications for patient health and well-being. But to fully exploit the value of this class of therapeutics […]
Pan Omics Summit May 21-22,2015 Boston, MA - We invite you to the attend the Pan-Omics Summit, which will take place May 21 – 22, 2015 in Boston, MA at the Hyatt Regency. This summit has four parallel tracks to discuss the developments and challenges in the popular omics areas of epigenomics, metabolomics, functional genomics, and next generation sequencing. Representatives from big pharma, […]
Paediatric Clinical Trials 25th – 26th March 2015, London, UK - A large number of medicines used in paediactric care have not been tested on children and are therefore used off lable or unlicensed. This absence of suitable authorised medicinal products to treat conditions in children is an issue that has been of concern for some time, and one that is increasingly coming to the fore. […]
Adaptive Designs in Clinical Trials 20th April to 21st April 2015, London, United Kingdom - Prior to the approval of new drugs, substantial evidence of efficacy is required and safety brought through clinical trials. A massive decline in success rates in Phase II/III of clinical trials has resulted in only 1 in 10 drugs successfully passing  through these trials in the US. With increasing pressure to bring drugs quickly into the market and reduce […]
5th Cancer Targets & Therapeutics Conference (July 7-8, 2014, Boston, MA) - With the rapid progression of molecular biology and genetics, and the subsequent emergence of many new targets, emerging targets and therapeutics provide new opportunities for the prevention and treatment of several major disease systems. The 5th Cancer Targets & Therapeutics Conference, taking place on July 7-8, 2014 in Boston, MA will continue to be a […]
Pain Therapeutics 19TH & 20TH MAY 2014 - Venue: Holiday Inn Regents Park Hotel, London, United Kingdom SMi are proud to present their 14th Annual Pain Therapeutics Conference taking place in Central London on Monday 19th and Tuesday 20th May 2014. This event will focus on the advances and challenges of pre-clinical and clinical aspects of pain drug development. The agenda will give […]
Mouse avatars of personalized cancer therapy - Over the last few decades, study of cancer in mouse models has gained popularity. Sophisticated genetic manipulation technologies and commercialization of these murine systems have made it possible to generate mice to study human disease. Given the large socio-economic burden of cancer, both on academic research and the health care industry, there is a need […]
Cambridge Healthtech Institute Announces the Preliminary Agendas for two e-Clinical conferences at SCOPE 2014 - Programs discuss collecting and leveraging data to optimize clinical trials & operations, portals, data warehouses, and site & study execution metrics. Sixth Annual Electronic Data in Clinical Trials February 4-5, 2014 Hyatt Regency Miami, Miami, FL SCOPEsummit.com/Electronic-Data Third Annual Integrating and Leveraging Clinical Trial Operations Data February 5-6, 2014 Hyatt Regency Miami, Miami, FL SCOPEsummit.com/Clinops-Data-Integration […]
X-Body BioSciences and Tanabe Research Labs Team Up to Develop mAbs for Autoimmune Diseases - X-Body Biosciences entered a partnership with Tanabe Research Laboratories (TRL) to identify therapeutic target epitopes and develop monospecific and/or bispecific antibodies against those targets. TRL is focussed on discovery and development of biologicals for autoimmune diseases. Under terms of the deal, X-Body will be responsible for screening, and TRL will fund the work. TRL has […]
Scientists Use Mutant Protein to Inhibit Cancer Stem Cells and Resensitize Tumors to Lapatinib - Blocking a cancer cell protein from binding to three other proteins may provide a new approach to cancer therapy that both reduces populations of breast cancer initiating cells (BCICs) in breast tumors and sensitizes the tumors to existing treatments such as lapatinib or paclitaxel, scientists claim. The technique uses a specially designed lipid-based vector to […]
Ark to Manufacture PsiOxus’ IV-Administered Oncolytic Virus for Clinical Trials - Ark Therapeutics negotiated a manufacturing partnership with PsiOxus Therapeutics for the latter’s ColoAd1 candidate for the treatment of colorectal cancer. Under terms of the agreement Ark will work with PsiOxus to generate an IV formulation of the adenovirus-based oncolytic product using its suspension-based single-use system (ATOSUS) for toxicological and Phase I/II clinical studies. ColoAd1 is […]
Experimental Type 1 diabetes vaccine fails during second step of trial - The quest for a vaccine to stop Type 1 diabetes in its tracks has hit a roadblock. An experimental drug failed in the second step of a three-phase trial on 145 American and Canadian patients who had just been diagnosed with the disease. The vaccine is based on an enzyme that is targeted by a […]




Category List
A to Z Company List
Allied Services
Building Blocks
cGMP
Software
Company Type
Contract Research, Procurement Services
Custom Synthesis
Logistics, Packaging, Shipping
Name Reactions
Natural Products
Process Services
Regional
Scientific Equipment
Screening Compounds
Specialty Chemicals
Volume Capacity
Web Links
Conferences and Trade Shows

News and Events

Media Partners
Become a Partner



Our Services
Advertisement on BioExpoonline.com
Contact BioExpoOnline
Link to BioExpoOnline
Media Partners
Partner with BioExpoOnline
Privacy and Terms of Use

Featured Links

MyriaScreen
LOPAC 1280
Search by Structure
Bioscreening News
Chemical Reagents
Chemistry Software
Chemistry Databases

Home | News | Advanced Search | List Your Company | Advertising | Terms | Account Login | Contact Us

2004-2007 BioScreening.com, All Rights Reserved